Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sandhya Appachu"'
Autor:
Aruna Korlimarla, PS Hari, Jyoti Prabhu, Chanthirika Ragulan, Yatish Patil, VP Snijesh, Krisha Desai, Aju Mathews, Sandhya Appachu, Ravi B. Diwakar, BS Srinath, Alan Melcher, Maggie Cheang, Anguraj Sadanandam
Publikováno v:
Translational Oncology, Vol 27, Iss , Pp 101574- (2023)
Externí odkaz:
https://doaj.org/article/8af7d49800d6483188b46b69120e86c7
Autor:
Aruna Korlimarla, Hari PS, Jyoti Prabhu, Chanthirika Ragulan, Yatish Patil, Snijesh VP, Krisha Desai, Aju Mathews, Sandhya Appachu, Ravi B. Diwakar, Srinath BS, Alan Melcher, Maggie Cheang, Anguraj Sadanandam
Publikováno v:
Translational Oncology, Vol 25, Iss , Pp 101511- (2022)
Purpose: Triple-negative breast cancer (TNBC) is a heterogeneous disease with a significant challenge to effectively manage in the clinic worldwide. Immunotherapy may be beneficial to TNBC patients if responders can be effectively identified. Here we
Externí odkaz:
https://doaj.org/article/a88adf8242244906823d8dcfed4bdb5f
Autor:
Linu A. Jacob, S. Aparna, K. C. Lakshmaiah, D. Lokanatha, Govind Babu, Suresh Babu, Sandhya Appachu
Publikováno v:
Advances in Hematology, Vol 2015 (2015)
Introduction. The incidence of Acute Myeloid Leukemia (AML) increases progressively with age and its treatment is challenging. This prospective case control study was undertaken to compare the safety, efficacy, and cost-effectiveness of decitabine wi
Externí odkaz:
https://doaj.org/article/21fd43548cf34cc9bc9921e5637b306d
Autor:
Aruna Korlimarla, PS Hari, Jyoti Prabhu, Chanthirika Ragulan, Yatish Patil, VP Snijesh, Krisha Desai, Aju Mathews, Sandhya Appachu, Ravi B. Diwakar, BS Srinath, Maggie Cheang, Anguraj Sadanandam
BackgroundTriple-negative breast cancer (TNBC) is a heterogeneous disease with a significant clinical challenge. TNBC alarmingly comprises 25-30% of breast cancers in India compared with only 10-15% in the West. However, immunotherapy was approved fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41218f739a5fc7fe90eebb5dd0d0ac59
https://doi.org/10.1101/2022.03.06.483159
https://doi.org/10.1101/2022.03.06.483159
Autor:
L. Dasappa, Vineetha Unnikrishnan, Pretesh Rohan Kiran, Smitha Saldanha, Venugopal Arroju, Linu Abraham Jacob, Lakshmaiah K Chinnagiriyappa, Aparna Sreevatsa, Suresh Babu Mallekavu, Govind Babu, Sandhya Appachu
Publikováno v:
Chemotherapy Research and Practice
Background. The efficacy, safety, and cost benefit of olanzapine (OLN) when compared to aprepitant (APR) in the prevention of chemotherapy induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC) were evaluated. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f56410129cfb95bcd4e5954dd372e35
https://doi.org/10.1155/2016/3439707
https://doi.org/10.1155/2016/3439707
Publikováno v:
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology
Posterior reversible encephalopathy syndrome (PRES) is a neurotoxic state coupled with a unique radio imaging appearance. We describe this rare, mostly reversible condition in five cases undergoing similar treatment under preset protocol (MCP-841) fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::037f5dec801ac3a4933080fc46e9ffa8
https://doi.org/10.4103/0971-5851.133727
https://doi.org/10.4103/0971-5851.133727
Autor:
Suresh Babu, D. Lokanatha, Sandhya Appachu, S. Aparna, K C Lakshmaiah, Linu Abraham Jacob, Govind Babu
Publikováno v:
Advances in Hematology, Vol 2015 (2015)
Advances in Hematology
Advances in Hematology
Introduction. The incidence of Acute Myeloid Leukemia (AML) increases progressively with age and its treatment is challenging. This prospective case control study was undertaken to compare the safety, efficacy, and cost-effectiveness of decitabine wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2436fbb538e554a97003dba7673922d3
https://doaj.org/article/21fd43548cf34cc9bc9921e5637b306d
https://doaj.org/article/21fd43548cf34cc9bc9921e5637b306d
Publikováno v:
Indian journal of surgical oncology. 2(4)
Soft tissue sarcomas (STS) comprise 1% of all cancers diagnosed worldwide with more than 40 different histological subtypes each with distinct underlying biology, natural history and response to treatment. Due to the differential chemosensitivity it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86e61dda60734fa885eb822f9a1f4afa
https://pubmed.ncbi.nlm.nih.gov/23204790
https://pubmed.ncbi.nlm.nih.gov/23204790